| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
9,860,000 |
| Market
Cap: |
4.34(M) |
| Last
Volume: |
343,990 |
Avg
Vol: |
274,696 |
| 52
Week Range: |
$0.258 - $0.76 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura™, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,283,690 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,979,170 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
3,747,968 |
3,747,968 |
| Total Sell Value |
$0 |
$0 |
$4,610,000 |
$4,610,000 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hsu Michael |
Director |
– • – |
2003-11-26 |
4 |
S |
$2.72 |
$13,600 |
D/D |
(5,000) |
28,117 |
|
- |
|
| Hsu Michael |
Director |
– • – |
2003-11-24 |
4 |
S |
$2.81 |
$23,567 |
D/D |
(8,400) |
33,117 |
|
- |
|
| Hsu Michael |
Director |
– • – |
2003-11-21 |
4 |
S |
$2.80 |
$5,880 |
D/D |
(2,100) |
41,517 |
|
- |
|
| Hsu Michael |
Director |
– • – |
2003-11-18 |
4 |
S |
$2.90 |
$27,550 |
D/D |
(9,500) |
43,167 |
|
- |
|
| Huckel Hubert E Md |
Director |
– • – |
2003-10-20 |
4 |
S |
$3.50 |
$3,500 |
I/I |
(1,000) |
3,000 |
|
- |
|
| Huckel Hubert E Md |
Director |
– • – |
2003-10-20 |
4 |
S |
$3.25 |
$162,718 |
D/D |
(48,900) |
36,600 |
|
- |
|
131 Records found
|
|
Page 6 of 6 |
|
|
